The histo-pathological examination revealed an astrocytoma WHO II, IDH1 mutated, and the patient was treated with proton radiation therapy and adjuvant chemotherapy with temozolomide. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).